Scholars Central

Research articlePublished 30 Apr 2015

Serum copeptin as severity and prognostic marker in hyperglycemic emergencies

Authors: Kehinde Sola Akinlade, Ademola Akinkunmi Azeez, Jokotade Oluremilekun Adeleye, Sheu Kadiri Rahamon

Annals of Biological Research

Volume 6 · Issue 4 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Despite the high mortality and morbidity associated with hyperglycemic emergencies (HEs), reliable biological markers that could predict the severity and prognosis are largely unavailable. This study therefore, assessed the performance of copeptin in predicting the severity and prognosis of HEs. Sixty patients with HEs [27 with diabetes ketoacidosis (DKA) and 33 with hyperglycemic hyperosmolar state (HHS)] were recruited into this cross-sectional study. Serum copeptin was determined using ELISA. Glasgow Coma Scale (GCS) was used to grade the severity of HE and the performance of copeptin in predicting the severity of HE was determined using the Area under the Receiver Operating Characteristic Curve (AUROC). Data analysis was done using the Student’s t-test, Mann Whitney U and Spearman correlation as appropriate. P<0.05 was considered as statistically significant. The median copeptin level was slightly higher in patients with HHS than in patients with DKA. In patients with moderately severe score of GCS (GMo), the median copeptin level was significantly higher when compared with patients with normal GCS score (GN). Assessing the performance of copeptin in predicting the severity of HE, copeptin had AUROC of 6.334 (P = 0.034) for GN and 0.738 (P = 0.011) for GMo. During the study, 10 patients (16.7%) died but the median copeptin level was only slightly higher in the patients that died (PD) than in patients that survived (PS). Also, the median copeptin level in patients who survived and were on admission for ≥ 11 days was slightly higher than in those that were admitted for ≤ 10 days. There was a significant inverse correlation between copeptin and GCS scores. Copeptin might not be a good prognostic marker in patients with hyperglycemic emergencies but had good performance in predicting patients with hyperglycemic emergencies with normal and moderately severe GCS scores

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Annals of Biological Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Biological Research
  • BylineArticles whose byline prints “Kehinde Sola Akinlade”
  • BylineArticles whose byline prints “Ademola Akinkunmi Azeez”
  • BylineArticles whose byline prints “Jokotade Oluremilekun Adeleye”
  • BylineArticles whose byline prints “Sheu Kadiri Rahamon”